Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49.8M
-
Number of holders
-
117
-
Total 13F shares, excl. options
-
62.1M
-
Shares change
-
-3.64M
-
Total reported value, excl. options
-
$696M
-
Value change
-
-$39.7M
-
Put/Call ratio
-
0.21
-
Number of buys
-
54
-
Number of sells
-
-55
-
Price
-
$11.22
Significant Holders of Theravance Biopharma, Inc. - Common Stock (TBPH) as of Q4 2022
147 filings reported holding TBPH - Theravance Biopharma, Inc. - Common Stock as of Q4 2022.
Theravance Biopharma, Inc. - Common Stock (TBPH) has 117 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 62.1M shares
.
Largest 10 shareholders include BAUPOST GROUP LLC/MA (11.4M shares), Weiss Asset Management LP (7.46M shares), Madison Avenue Partners, LP (7.01M shares), VANGUARD GROUP INC (5.56M shares), BlackRock Inc. (5.33M shares), FMR LLC (2.47M shares), Park West Asset Management LLC (1.92M shares), Irenic Capital Management LP (1.7M shares), D. E. Shaw & Co., Inc. (1.57M shares), and Newtyn Management, LLC (1.45M shares).
This table shows the top 117 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.